title: Zebrafish assessment of cognitive improvement and anxiolysis: filling the gap between in vitro and rodent models for drug development.
abstract: Zebrafish can provide a valuable animal model to screen potential cognitive enhancing and anxiolytic drugs. They are economical and can provide a relatively quick indication of possible functional efficacy. In as much as they have a complex nervous system and elaborate behavioral repertoire, zebrafish can provide a good intermediate model between in vitro receptor and cell-based assays and classic mammalian models for drug screening. In addition, the variety of molecular tools available in zebrafish makes them outstanding models for helping to determine the neuromolecular mechanisms for psychoactive drugs. However, to use zebrafish as a translational model we must have validated, sensitive and efficient behavioral tests. In a series of studies, our lab has developed tests of cognitive function and stress response, which are sensitive to drug effects in a similar manner as rodent models and humans for cognitive enhancement and alleviating stress response. In particular, the three-chamber task for learning and memory was shown to be sensitive to the cognitive enhancing effects of nicotine and has been useful in helping to determine neural mechanisms crucial for nicotinic-induced cognitive enhancement. The novel tank diving test was shown to be a valid and efficient test of stress response. It is sensitive to the reduction in stress-related behaviors due to the amxiolytic drugs diazepam and buspirone but not chlordiazepoxide. Nicotine also causes stress alleviating effects which can be interpreted as anxiolytic effects. Zebrafish models of behavioral pharmacology can be useful to efficiently screen test compounds for drug development and can be useful in helping to determine the mechanisms crucial for new therapeutic treatments of neurobehavioral impairments.
authors: Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Box #104790, Durham, NC 27710, USA. edlevin@duke.edu
authors: Edward D
authors: ED
authors: Levin
references: Behav Brain Res. 2010 Mar 5;207(2):223-31
references: 19836422
references: Behav Brain Res. 2009 Jan 23;196(2):323-7
references: 18926855
references: Neurotoxicol Teratol. 2003 Jan-Feb;25(1):51-7
references: 12633736
references: J Neurochem. 2004 Jan;88(2):443-53
references: 14690532
references: Biochem Biophys Res Commun. 1985 Feb 28;127(1):63-70
references: 2983718
references: Expert Opin Investig Drugs. 2005 May;14(5):601-18
references: 15926867
references: Psychopharmacology (Berl). 2009 Jan;202(1-3):103-9
references: 18716760
references: Behav Brain Res. 2008 Nov 3;193(1):148-51
references: 18573546
references: Behav Brain Res. 2008 Jan 10;186(1):107-17
references: 17854920
references: Braz J Med Biol Res. 1999 Jan;32(1):99-106
references: 10347776
references: Curr Biol. 2004 May 25;14(10):881-4
references: 15186744
references: Science. 2010 Jan 15;327(5963):348-51
references: 20075256
references: Exp Toxicol Pathol. 2003 Jul;55(1):69-83
references: 12940631
references: Gene Expr Patterns. 2003 Dec;3(6):747-54
references: 14643683
references: Psychopharmacology (Berl). 2006 Mar;184(3-4):547-52
references: 16175402
references: Neurobiol Learn Mem. 2007 Jan;87(1):72-7
references: 16861014
references: Mech Dev. 2001 Mar;101(1-2):237-43
references: 11231083
references: J Neurobiol. 2006 Aug;66(9):977-90
references: 16779826
references: Neurotoxicol Teratol. 2004 Nov-Dec;26(6):757-68
references: 15451040
references: Neuroreport. 2002 Jul 2;13(9):1097-106
references: 12151749
references: Physiol Behav. 2008 Jan 28;93(1-2):160-71
references: 17889042
references: Int J Comp Psychol. 2010 Jan 1;23(1):43-61
references: 20523756
references: Behav Res Methods. 2006 Aug;38(3):456-69
references: 17186756
references: Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11691-6
references: 11553778
references: Psychopharmacology (Berl). 2006 Mar;184(3-4):523-39
references: 16220335
references: Behav Brain Res. 2009 Mar 2;198(1):190-8
references: 19056431
references: Behav Brain Res. 2009 Dec 14;205(1):38-44
references: 19540270
references: Behav Brain Res. 2007 Dec 3;184(2):157-66
references: 17707522
references: Behav Brain Res. 2010 Dec 25;214(2):157-71
references: 20510300
references: Physiol Behav. 2007 Jan 30;90(1):54-8
references: 17049956
references: J Neurobiol. 1999 May;39(2):197-206
references: 10235674
references: Curr Opin Neurobiol. 1997 Feb;7(1):119-26
references: 9039801
references: Behav Processes. 2005 Aug 31;70(1):19-31
references: 15967284
references: Neurotoxicol Teratol. 2004 Nov-Dec;26(6):731-5
references: 15451037
references: Behav Brain Res. 2009 Aug 12;201(2):318-24
references: 19428651
references: Behav Brain Res. 2010 Apr 2;208(2):509-15
references: 20043955
references: Br J Pharmacol. 1985 Jan;84(1):19-25
references: 3978310
references: Physiol Behav. 2008 Oct 20;95(3):408-12
references: 18671990
references: Psychopharmacol Bull. 1986;22(3):865-9
references: 3797589
references: Pharmacol Biochem Behav. 2009 Nov;94(1):75-80
references: 19643124
references: Behav Brain Res. 2008 May 16;189(1):216-9
references: 18243353
references: J Neurobiol. 2000 Jun 15;43(4):389-403
references: 10861564
references: Behav Processes. 2002 Jun 28;58(3):125-132
references: 12044689
references: Proc Natl Acad Sci U S A. 1974 Jun;71(6):2246-50
references: 4152296
references: Behav Brain Res. 2010 Dec 25;214(2):332-42
references: 20540966
references: Brain Res Bull. 2008 Mar 18;75(2-4):433-41
references: 18331912